Pharma: Other News To Note
Teva Pharmaceutical Industries Ltd., of Jerusalem, launched its generic equivalent of Symbyax (olanzapine and fluoxetine, Eli Lilly and Co.) in the U.S.
To continue reading subscribe now to BioWorld Today
Learn More about BioWorld Today
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.